Merck Essay

710 Words2 Pages

The Deceivers of Drugs Merck and FDA

Introduction

A blockbuster drug, Rofecoxib, with sales of 2.5 billion dollars of annual sales was pulled off the market (Topol, 2004). The drug was pulled off after epidemiological studies had noted 1.4 million people have had a serious side effect (Medscape Medical News, 2004; Topol, 2004). Rofecoxib side effects were all associated with myocardial infarction, cardiovascular risks, and even death (Smith, 2007; Topol, 2004). Merck a drug manufacturing company and the Food and Drug Administration (FDA) commissioners apparently did not or concealed relevant data from the public that would otherwise be known to protect population health.

A summary of the facts associated with the case including the primary leaders

The rights to protect the public were brutal to public trust provided that the leaders of Merck and the FDA abused their powers to gain social control by deliberately marketing a deadly drug (Mumford, Zaccaro, Harding, Jacobs, & Fleishman, 2000; Smith, 2007). The leaders involved that of FDA commissioners received data from Merck regarding Rofecoxib also known as Vioxx about the health risks, yet failed to release …show more content…

Dr. Topol issued in the New England Journal of Medicine stating “ The senior executives at Merck and the leadership at the FDA share responsibility for not having taken appropriate action and not recognizing that they are accountable for the public health…” (Medscape Medical News, 2004, para. 7). Dr. Topol, skilled approach leadership role along with his traits as a leading cardiologist, was simply to acknowledge that FDA leaders and Merck demonstrated poor and corrupt leadership traits, which eventually cost the lives of his patients and their significant

More about Merck Essay

Open Document